"Because we are in a health care setting, masks are still required in all facilities. Thank you for helping keep our patients and staff safe."

During the past decade, University of Colorado Cancer Center conducted 155 clinical trials. In the 10-year time frame, 155 clinical trials started and 130 clinical trials were completed, i.e. on average, 83.9% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 65 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Colorado Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 97 trials, followed by "Radiation Therapy Oncology Group" with 54 trials sponsored, "University of Colorado, Denver" with 42 trials sponsored, "Gynecologic Oncology Group" with 36 trials sponsored and "Alliance for Clinical Trials in Oncology" with 36 trials sponsored. Other sponsors include 288 different institutions and companies that sponsored additional 174 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Colorado Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 253 trials as a collaborator, "SWOG Cancer Research Network" with 18 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Eastern Cooperative Oncology Group" with 14 trials as a collaborator and "Cancer and Leukemia Group B" with 13 trials as a collaborator. Other collaborators include 138 different institutions and companies that were collaborators in the rest 89 trials.

According to Clinical.Site data, the most researched conditions in "University of Colorado Cancer Center" are "Breast Cancer" (53 trials), "Lung Cancer" (37 trials), "Ovarian Cancer" (29 trials), "Head and Neck Cancer" (26 trials) and "Prostate Cancer" (24 trials). Many other conditions were trialed in "University of Colorado Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Colorado Cancer Center" are "Drug" (436 trials), "Radiation" (98 trials), "Biological" (90 trials), "Procedure" (69 trials) and "Other" (25 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (62 trials), "cisplatin" (43 trials), "paclitaxel" (43 trials), "Placebo" (25 trials) and "cyclophosphamide" (23 trials). Other intervention names were less common.

The vast majority of trials in "University of Colorado Cancer Center" are 405 trials for "All" genders, 99 trials for "Female" genders and 34 trials for "Male" genders.

Currently, there are NaN active trials in "University of Colorado Cancer Center". undefined are not yet recruiting, 45 are recruiting, 56 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 351 completed trials in University of Colorado Cancer Center, undefined suspended trials, and 65 terminated clinical trials to date.

Out of the total trials that were conducted in University of Colorado Cancer Center, 111 "Phase 1" clinical trials were conducted, 268 "Phase 2" clinical trials and 160 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 18 trials that are defined as “Not Applicable".